Cromakalim Inhibitor

Cromakalim, a potassium channel-opening vasodilator, acts on ATP-sensitive potassium channels and so causes membrane hyperpolarization, it can be used to treat hypertension as it will relax vascular smooth muscle to lower blood pressure. The active isomer is levcromakalim.

Cecchetti V, Tabarrini O, Sabatini S. From cromakalim to different structural classes of K(ATP) channel openers. Curr Top Med Chem. 2006;6(10):1049-68. Review. PubMed PMID: 16787279.
Moreau C, Prost AL, Derand R, Vivaudou M. SUR, ABC proteins targeted by KATP channel openers. J Mol Cell Cardiol. 2005 Jun;38(6):951-63. Epub 2005 Feb 19. Review. PubMed PMID: 15910880.
Khan IA, Gowda RM. Novel therapeutics for treatment,of long-QT syndrome and torsade de pointes. Int J Cardiol. 2004 May;95(1):1-6. Review. PubMed PMID: 15159030.
Sebille S, De Tullio P, Boverie S, Antoine MH, Lebrun P, Pirotte B. Recent developments in the chemistry of potassium channel activators: the cromakalim analogs. Curr Med Chem. 2004 May;11(9):1213-22. Review. PubMed PMID: 15134515.

Small volumes of Cromakalim, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756760 is an inhibitor targeting Cromakalim.